These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24063930)

  • 21. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System.
    Testa L; Latib A; De Marco F; De Carlo M; Agnifili M; Latini RA; Petronio AS; Ettori F; Poli A; De Servi S; Ramondo A; Napodano M; Klugmann S; Ussia GP; Tamburino C; Brambilla N; Colombo A; Bedogni F
    Circulation; 2013 Mar; 127(12):1300-7. PubMed ID: 23443735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve.
    Franzoni I; Latib A; Maisano F; Costopoulos C; Testa L; Figini F; Giannini F; Basavarajaiah S; Mussardo M; Slavich M; Taramasso M; Cioni M; Longoni M; Ferrarello S; Radinovic A; Sala S; Ajello S; Sticchi A; Giglio M; Agricola E; Chieffo A; Montorfano M; Alfieri O; Colombo A
    Am J Cardiol; 2013 Aug; 112(4):554-9. PubMed ID: 23726173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innovative technology-transcatheter aortic valve implantation: cost and reimbursement issues.
    Dahle G; Rein KA; Fiane A; Fosse E; Khushi I; Hagen T; Mishra V
    Scand Cardiovasc J; 2012 Dec; 46(6):345-52. PubMed ID: 22917262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients.
    Unbehaun A; Pasic M; Dreysse S; Drews T; Kukucka M; Mladenow A; Ivanitskaja-Kühn E; Hetzer R; Buz S
    J Am Coll Cardiol; 2012 Jan; 59(3):211-21. PubMed ID: 22240125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study.
    Stähli BE; Grünenfelder J; Jacobs S; Falk V; Landmesser U; Wischnewsky MB; Lüscher TF; Corti R; Maier W; Altwegg LA
    J Invasive Cardiol; 2012 Aug; 24(8):407-11. PubMed ID: 22865312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation.
    Yong ZY; Wiegerinck EM; Boerlage-van Dijk K; Koch KT; Vis MM; Bouma BJ; Henriques JP; Cocchieri R; Piek JJ; de Mol BA; Baan J
    Circ Cardiovasc Interv; 2012 Jun; 5(3):415-23. PubMed ID: 22668556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter aortic valve implantation without balloon predilation: a single-center pilot experience.
    Mendiz OA; Fraguas H; Lev GA; Valdivieso LR; Favaloro RR
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):292-7. PubMed ID: 23554013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry.
    Onorati F; D'Errigo P; Barbanti M; Rosato S; Covello RD; Maraschini A; Ranucci M; Santoro G; Tamburino C; Grossi C; Santini F; Menicanti L; Seccareccia F;
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1529-39. PubMed ID: 23856202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?
    Watanabe Y; Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    Catheter Cardiovasc Interv; 2013 May; 81(6):1053-60. PubMed ID: 23074135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
    Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
    J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis.
    Chorianopoulos E; Krumsdorf U; Geis N; Pleger ST; Giannitsis E; Katus HA; Bekeredjian R
    Clin Res Cardiol; 2014 Jan; 103(1):65-72. PubMed ID: 24096554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transcatheter aortic valve implantation in patients with severe aortic stenosis].
    Bjerre Thygesen J; Loh PH; Franzen O; Søndergaard L
    Ugeskr Laeger; 2012 Oct; 174(43):2620-4. PubMed ID: 23095650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of cerebral injury following transfemoral aortic valve implantation.
    Ghanem A; Müller A; Sinning JM; Kocurek J; Becker BV; Vogel M; Vasa-Nicotera M; Hammerstingl C; Schwab JO; Nähle CP; Thomas D; Wagner M; Grube E; Werner N; Nickenig G
    EuroIntervention; 2013 Mar; 8(11):1296-306. PubMed ID: 23538093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transapical aortic valve implantation--indications, risks and limitations].
    Kappert U; Joskowiak D; Tugtekin SM; Matschke K
    Clin Res Cardiol Suppl; 2011 May; 6():49-57. PubMed ID: 22528178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of myocardial injury following transcatheter aortic valve implantation.
    Carrabba N; Valenti R; Migliorini A; Vergara R; Parodi G; Antoniucci D
    Am J Cardiol; 2013 May; 111(10):1475-81. PubMed ID: 23465097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and effect of myocardial injury after transcatheter aortic valve replacement.
    Barbash IM; Dvir D; Ben-Dor I; Badr S; Okubagzi P; Torguson R; Corso PJ; Xue Z; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2013 May; 111(9):1337-43. PubMed ID: 23415511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive review of the PARTNER trial.
    Svensson LG; Tuzcu M; Kapadia S; Blackstone EH; Roselli EE; Gillinov AM; Sabik JF; Lytle BW
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S11-6. PubMed ID: 23410766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement.
    Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
    Am J Cardiol; 2013 Mar; 111(6):891-7. PubMed ID: 23337835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.